The ways of science can be quite long-winded and intricate sometimes:
In such a project, Obleserlab team members Sarah Tune and myself (J.O.) had been making interesting contact with the very remote fields of biochemistry and infectiology, through the lab of Lübeck‘s Thomas Krey and their quite exciting project: Designing a new candidate for an hitherto unavailable vaccine against the Hepatitis C virus; and then going on to test its potency in a series of experiments.
Ultimately, the Obleserlab contributed statistical modelling for these experimental data — The final paper is now out in Science Advances. Sarah and I (J.O.) made it a mission to apply some state-of-the-art linear mixed models and adequate data transforms not commonly used in this kind of work (see screenshot attached.)
Thanks to Kumar and Thomas and all teams involved, for letting us venture far outside of our comfort zone with this intriguing collaborative effort.
